1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Major Depressive Disorder (MDD) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Antidepressant Drugs 1.2.3 SSRIs 1.2.4 SNRIs 1.2.5 Benzodiazepines 1.2.6 Others 1.3 Market by Application 1.3.1 Global Major Depressive Disorder (MDD) Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Major Depressive Disorder (MDD) Market Perspective (2017-2028) 2.2 Major Depressive Disorder (MDD) Growth Trends by Region 2.2.1 Major Depressive Disorder (MDD) Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Major Depressive Disorder (MDD) Historic Market Size by Region (2017-2022) 2.2.3 Major Depressive Disorder (MDD) Forecasted Market Size by Region (2023-2028) 2.3 Major Depressive Disorder (MDD) Market Dynamics 2.3.1 Major Depressive Disorder (MDD) Industry Trends 2.3.2 Major Depressive Disorder (MDD) Market Drivers 2.3.3 Major Depressive Disorder (MDD) Market Challenges 2.3.4 Major Depressive Disorder (MDD) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Major Depressive Disorder (MDD) Players by Revenue 3.1.1 Global Top Major Depressive Disorder (MDD) Players by Revenue (2017-2022) 3.1.2 Global Major Depressive Disorder (MDD) Revenue Market Share by Players (2017-2022) 3.2 Global Major Depressive Disorder (MDD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Major Depressive Disorder (MDD) Revenue 3.4 Global Major Depressive Disorder (MDD) Market Concentration Ratio 3.4.1 Global Major Depressive Disorder (MDD) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Major Depressive Disorder (MDD) Revenue in 2021 3.5 Major Depressive Disorder (MDD) Key Players Head office and Area Served 3.6 Key Players Major Depressive Disorder (MDD) Product Solution and Service 3.7 Date of Enter into Major Depressive Disorder (MDD) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Major Depressive Disorder (MDD) Breakdown Data by Type 4.1 Global Major Depressive Disorder (MDD) Historic Market Size by Type (2017-2022) 4.2 Global Major Depressive Disorder (MDD) Forecasted Market Size by Type (2023-2028) 5 Major Depressive Disorder (MDD) Breakdown Data by Application 5.1 Global Major Depressive Disorder (MDD) Historic Market Size by Application (2017-2022) 5.2 Global Major Depressive Disorder (MDD) Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Major Depressive Disorder (MDD) Market Size (2017-2028) 6.2 North America Major Depressive Disorder (MDD) Market Size by Country (2017-2022) 6.3 North America Major Depressive Disorder (MDD) Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Major Depressive Disorder (MDD) Market Size (2017-2028) 7.2 Europe Major Depressive Disorder (MDD) Market Size by Country (2017-2022) 7.3 Europe Major Depressive Disorder (MDD) Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Major Depressive Disorder (MDD) Market Size (2017-2028) 8.2 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Country (2017-2022) 8.3 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Major Depressive Disorder (MDD) Market Size (2017-2028) 9.2 Latin America Major Depressive Disorder (MDD) Market Size by Country (2017-2022) 9.3 Latin America Major Depressive Disorder (MDD) Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Major Depressive Disorder (MDD) Market Size (2017-2028) 10.2 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2017-2022) 10.3 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Detail 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Major Depressive Disorder (MDD) Introduction 11.1.4 Pfizer Revenue in Major Depressive Disorder (MDD) Business (2017-2022) 11.1.5 Pfizer Recent Development 11.2 GlaxoSmithKline 11.2.1 GlaxoSmithKline Company Detail 11.2.2 GlaxoSmithKline Business Overview 11.2.3 GlaxoSmithKline Major Depressive Disorder (MDD) Introduction 11.2.4 GlaxoSmithKline Revenue in Major Depressive Disorder (MDD) Business (2017-2022) 11.2.5 GlaxoSmithKline Recent Development 11.3 Merck 11.3.1 Merck Company Detail 11.3.2 Merck Business Overview 11.3.3 Merck Major Depressive Disorder (MDD) Introduction 11.3.4 Merck Revenue in Major Depressive Disorder (MDD) Business (2017-2022) 11.3.5 Merck Recent Development 11.4 AstraZeneca 11.4.1 AstraZeneca Company Detail 11.4.2 AstraZeneca Business Overview 11.4.3 AstraZeneca Major Depressive Disorder (MDD) Introduction 11.4.4 AstraZeneca Revenue in Major Depressive Disorder (MDD) Business (2017-2022) 11.4.5 AstraZeneca Recent Development 11.5 Eli Lily 11.5.1 Eli Lily Company Detail 11.5.2 Eli Lily Business Overview 11.5.3 Eli Lily Major Depressive Disorder (MDD) Introduction 11.5.4 Eli Lily Revenue in Major Depressive Disorder (MDD) Business (2017-2022) 11.5.5 Eli Lily Recent Development 11.6 Johnson & Johnson 11.6.1 Johnson & Johnson Company Detail 11.6.2 Johnson & Johnson Business Overview 11.6.3 Johnson & Johnson Major Depressive Disorder (MDD) Introduction 11.6.4 Johnson & Johnson Revenue in Major Depressive Disorder (MDD) Business (2017-2022) 11.6.5 Johnson & Johnson Recent Development 11.7 Forest Laboratories 11.7.1 Forest Laboratories Company Detail 11.7.2 Forest Laboratories Business Overview 11.7.3 Forest Laboratories Major Depressive Disorder (MDD) Introduction 11.7.4 Forest Laboratories Revenue in Major Depressive Disorder (MDD) Business (2017-2022) 11.7.5 Forest Laboratories Recent Development 11.8 Sanofi-Aventis 11.8.1 Sanofi-Aventis Company Detail 11.8.2 Sanofi-Aventis Business Overview 11.8.3 Sanofi-Aventis Major Depressive Disorder (MDD) Introduction 11.8.4 Sanofi-Aventis Revenue in Major Depressive Disorder (MDD) Business (2017-2022) 11.8.5 Sanofi-Aventis Recent Development 11.9 H. Lundbeck 11.9.1 H. Lundbeck Company Detail 11.9.2 H. Lundbeck Business Overview 11.9.3 H. Lundbeck Major Depressive Disorder (MDD) Introduction 11.9.4 H. Lundbeck Revenue in Major Depressive Disorder (MDD) Business (2017-2022) 11.9.5 H. Lundbeck Recent Development 11.10 Bristol-Myers Squibb 11.10.1 Bristol-Myers Squibb Company Detail 11.10.2 Bristol-Myers Squibb Business Overview 11.10.3 Bristol-Myers Squibb Major Depressive Disorder (MDD) Introduction 11.10.4 Bristol-Myers Squibb Revenue in Major Depressive Disorder (MDD) Business (2017-2022) 11.10.5 Bristol-Myers Squibb Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Major Depressive Disorder (MDD) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Antidepressant Drugs Table 3. Key Players of SSRIs Table 4. Key Players of SNRIs Table 5. Key Players of Benzodiazepines Table 6. Key Players of Others Table 7. Global Major Depressive Disorder (MDD) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Major Depressive Disorder (MDD) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Major Depressive Disorder (MDD) Market Size by Region (2017-2022) & (US$ Million) Table 10. Global Major Depressive Disorder (MDD) Market Share by Region (2017-2022) Table 11. Global Major Depressive Disorder (MDD) Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 12. Global Major Depressive Disorder (MDD) Market Share by Region (2023-2028) Table 13. Major Depressive Disorder (MDD) Market Trends Table 14. Major Depressive Disorder (MDD) Market Drivers Table 15. Major Depressive Disorder (MDD) Market Challenges Table 16. Major Depressive Disorder (MDD) Market Restraints Table 17. Global Major Depressive Disorder (MDD) Revenue by Players (2017-2022) & (US$ Million) Table 18. Global Major Depressive Disorder (MDD) Market Share by Players (2017-2022) Table 19. Global Top Major Depressive Disorder (MDD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Major Depressive Disorder (MDD) as of 2021) Table 20. Ranking of Global Top Major Depressive Disorder (MDD) Companies by Revenue (US$ Million) in 2021 Table 21. Global 5 Largest Players Market Share by Major Depressive Disorder (MDD) Revenue (CR5 and HHI) & (2017-2022) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Major Depressive Disorder (MDD) Product Solution and Service Table 24. Date of Enter into Major Depressive Disorder (MDD) Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Major Depressive Disorder (MDD) Market Size by Type (2017-2022) & (US$ Million) Table 27. Global Major Depressive Disorder (MDD) Revenue Market Share by Type (2017-2022) Table 28. Global Major Depressive Disorder (MDD) Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 29. Global Major Depressive Disorder (MDD) Revenue Market Share by Type (2023-2028) Table 30. Global Major Depressive Disorder (MDD) Market Size by Application (2017-2022) & (US$ Million) Table 31. Global Major Depressive Disorder (MDD) Revenue Market Share by Application (2017-2022) Table 32. Global Major Depressive Disorder (MDD) Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 33. Global Major Depressive Disorder (MDD) Revenue Market Share by Application (2023-2028) Table 34. North America Major Depressive Disorder (MDD) Market Size by Country (2017-2022) & (US$ Million) Table 35. North America Major Depressive Disorder (MDD) Market Size by Country (2023-2028) & (US$ Million) Table 36. Europe Major Depressive Disorder (MDD) Market Size by Country (2017-2022) & (US$ Million) Table 37. Europe Major Depressive Disorder (MDD) Market Size by Country (2023-2028) & (US$ Million) Table 38. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2017-2022) & (US$ Million) Table 39. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2023-2028) & (US$ Million) Table 40. Latin America Major Depressive Disorder (MDD) Market Size by Country (2017-2022) & (US$ Million) Table 41. Latin America Major Depressive Disorder (MDD) Market Size by Country (2023-2028) & (US$ Million) Table 42. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2017-2022) & (US$ Million) Table 43. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2023-2028) & (US$ Million) Table 44. Pfizer Company Detail Table 45. Pfizer Business Overview Table 46. Pfizer Major Depressive Disorder (MDD) Product Table 47. Pfizer Revenue in Major Depressive Disorder (MDD) Business (2017-2022) & (US$ Million) Table 48. Pfizer Recent Development Table 49. GlaxoSmithKline Company Detail Table 50. GlaxoSmithKline Business Overview Table 51. GlaxoSmithKline Major Depressive Disorder (MDD) Product Table 52. GlaxoSmithKline Revenue in Major Depressive Disorder (MDD) Business (2017-2022) & (US$ Million) Table 53. GlaxoSmithKline Recent Development Table 54. Merck Company Detail Table 55. Merck Business Overview Table 56. Merck Major Depressive Disorder (MDD) Product Table 57. Merck Revenue in Major Depressive Disorder (MDD) Business (2017-2022) & (US$ Million) Table 58. Merck Recent Development Table 59. AstraZeneca Company Detail Table 60. AstraZeneca Business Overview Table 61. AstraZeneca Major Depressive Disorder (MDD) Product Table 62. AstraZeneca Revenue in Major Depressive Disorder (MDD) Business (2017-2022) & (US$ Million) Table 63. AstraZeneca Recent Development Table 64. Eli Lily Company Detail Table 65. Eli Lily Business Overview Table 66. Eli Lily Major Depressive Disorder (MDD) Product Table 67. Eli Lily Revenue in Major Depressive Disorder (MDD) Business (2017-2022) & (US$ Million) Table 68. Eli Lily Recent Development Table 69. Johnson & Johnson Company Detail Table 70. Johnson & Johnson Business Overview Table 71. Johnson & Johnson Major Depressive Disorder (MDD) Product Table 72. Johnson & Johnson Revenue in Major Depressive Disorder (MDD) Business (2017-2022) & (US$ Million) Table 73. Johnson & Johnson Recent Development Table 74. Forest Laboratories Company Detail Table 75. Forest Laboratories Business Overview Table 76. Forest Laboratories Major Depressive Disorder (MDD) Product Table 77. Forest Laboratories Revenue in Major Depressive Disorder (MDD) Business (2017-2022) & (US$ Million) Table 78. Forest Laboratories Recent Development Table 79. Sanofi-Aventis Company Detail Table 80. Sanofi-Aventis Business Overview Table 81. Sanofi-Aventis Major Depressive Disorder (MDD) Product Table 82. Sanofi-Aventis Revenue in Major Depressive Disorder (MDD) Business (2017-2022) & (US$ Million) Table 83. Sanofi-Aventis Recent Development Table 84. H. Lundbeck Company Detail Table 85. H. Lundbeck Business Overview Table 86. H. Lundbeck Major Depressive Disorder (MDD) Product Table 87. H. Lundbeck Revenue in Major Depressive Disorder (MDD) Business (2017-2022) & (US$ Million) Table 88. H. Lundbeck Recent Development Table 89. Bristol-Myers Squibb Company Detail Table 90. Bristol-Myers Squibb Business Overview Table 91. Bristol-Myers Squibb Major Depressive Disorder (MDD) Product Table 92. Bristol-Myers Squibb Revenue in Major Depressive Disorder (MDD) Business (2017-2022) & (US$ Million) Table 93. Bristol-Myers Squibb Recent Development Table 94. Research Programs/Design for This Report Table 95. Key Data Information from Secondary Sources Table 96. Key Data Information from Primary Sources List of Figures Figure 1. Global Major Depressive Disorder (MDD) Market Share by Type: 2021 VS 2028 Figure 2. Antidepressant Drugs Features Figure 3. SSRIs Features Figure 4. SNRIs Features Figure 5. Benzodiazepines Features Figure 6. Others Features Figure 7. Global Major Depressive Disorder (MDD) Market Share by Application in 2021 & 2028 Figure 8. Hospitals Case Studies Figure 9. Clinics Case Studies Figure 10. Others Case Studies Figure 11. Major Depressive Disorder (MDD) Report Years Considered Figure 12. Global Major Depressive Disorder (MDD) Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Major Depressive Disorder (MDD) Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Major Depressive Disorder (MDD) Market Share by Region: 2021 VS 2028 Figure 15. Global Major Depressive Disorder (MDD) Market Share by Players in 2021 Figure 16. Global Top Major Depressive Disorder (MDD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Major Depressive Disorder (MDD) as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Major Depressive Disorder (MDD) Revenue in 2021 Figure 18. North America Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Major Depressive Disorder (MDD) Market Share by Country (2017-2028) Figure 20. United States Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Major Depressive Disorder (MDD) Market Share by Country (2017-2028) Figure 24. Germany Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Major Depressive Disorder (MDD) Market Share by Region (2017-2028) Figure 32. China Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Major Depressive Disorder (MDD) Market Share by Country (2017-2028) Figure 40. Mexico Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Major Depressive Disorder (MDD) Market Share by Country (2017-2028) Figure 44. Turkey Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Major Depressive Disorder (MDD) Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Pfizer Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2017-2022) Figure 47. GlaxoSmithKline Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2017-2022) Figure 48. Merck Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2017-2022) Figure 49. AstraZeneca Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2017-2022) Figure 50. Eli Lily Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2017-2022) Figure 51. Johnson & Johnson Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2017-2022) Figure 52. Forest Laboratories Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2017-2022) Figure 53. Sanofi-Aventis Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2017-2022) Figure 54. H. Lundbeck Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2017-2022) Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2017-2022) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Pfizer GlaxoSmithKline Merck AstraZeneca Eli Lily Johnson & Johnson Forest Laboratories Sanofi-Aventis H. Lundbeck Bristol-Myers Squibb